Search Results - "Hartman, Taymar"
-
1
Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies
Published in Biotechnology and bioengineering (01-02-2007)“…Presented is a novel antibody production platform based on the fed‐batch culture of recombinant, NS0‐derived cell lines. A standardized fed‐batch cell culture…”
Get full text
Journal Article -
2
Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies
Published in Biotechnology and bioengineering (01-02-2007)“…Presented is an antibody production platform based on the fed‐batch culture of recombinant NS0‐derived cell lines. NS0 host cells, obtained from the European…”
Get full text
Journal Article -
3
Protein-free fed-batch culture of non-GS NSO cell lines for production of recombinant antibodies
Published in Biotechnology and bioengineering (01-02-2007)Get full text
Journal Article -
4
Advancing Biologics Development Programs with Legacy Cell Lines: Advantages and Limitations of Genetic Testing for Addressing Clonality Concerns Prior to Availability of Late Stage Process and Product Consistency Data
Published in PDA journal of pharmaceutical science and technology (01-03-2020)“…The bioprocessing industry uses recombinant mammalian cell lines to generate therapeutic biologic drugs. To ensure consistent product quality of the…”
Get more information
Journal Article -
5
PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis
Published in Arthritis research & therapy (01-01-2013)“…Targeting the CD20 antigen has been a successful therapeutic intervention in the treatment of rheumatoid arthritis (RA). However, in some patients with an…”
Get full text
Journal Article -
6